Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

50.76 -0.29 (-0.57%)

Streaming Delayed Price Updated: 10:12 AM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

45 46 Next >

WHO Recommends Against Roche, GSK's COVID-19 Therapies Rendering Them Obsolete ↗

September 16, 2022

Due to the lack of effectiveness against omicron and the variants, World Health Organization (WHO) no longer recommends using two COVID-19 antibody therapies.

Via Benzinga

Pfizer's Pentavalent Meningococcal Vaccine Candidate Shows Efficacy In Adolescents ↗

September 15, 2022

Via Benzinga

AnaptysBio Sells Royalty Interest In Cancer Drug For $45M ↗

September 12, 2022

Via Benzinga

September 2022 Stock Considerations ↗

September 08, 2022

Let’s take a look at my September stock considerations which are similar to recent considerations from one to four months ago.

Via Talk Markets

SpringWorks Shares Pop After Expanded Multiple Myeloma Pact With GSK ↗

September 07, 2022

Via Benzinga

Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report ↗

September 06, 2022

Via Benzinga

GSK's Rare Blood Cancer Candidate Goes Under FDA Review ↗

August 17, 2022

Via Benzinga

One Suit Down Out Of 3,000 Zantac Related Lawsuits, Says GSK ↗

August 17, 2022

Via Benzinga

Why IDEAYA Biosciences Shares Plunging Today ↗

August 15, 2022

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

Novartis Appoints Merck Executive As Research Head ↗

September 01, 2022

Via Benzinga

With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report ↗

August 30, 2022

Via Benzinga

IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate ↗

August 29, 2022

Via Benzinga

Is Sanofi A Buy, Despite Recent Stumbles?

August 19, 2022

Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.

Via MarketBeat

Topics Intellectual Property

Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation ↗

August 18, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 18, 2022

During Thursday's trading, 62 companies set new 52-week lows.

Via Benzinga

Recent Stock Purchase August 2022 ↗

August 18, 2022

I just continue to have a long-term outlook, continue to invest, diversify my portfolio even more and just hold on.

Via Talk Markets

Sanofi's Run Of Bad Luck Continues As Pharma Giant Tosses Out A Cancer Drug ↗

August 17, 2022

Shares extended deep losses following a Zantac-inspired downturn last week.

Via Investor's Business Daily

AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report ↗

August 17, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

August 15, 2022

On Monday, 31 companies hit new 52-week lows.

Via Benzinga

ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm

August 15, 2022

From The Schall Law Firm

Via Business Wire

Landmark Drug Pricing Reform Bill Passes Congress House ↗

August 15, 2022

The U.S. House of Representatives voted 220-207 to pass new, wide-ranging legislation allowing Medicare drug price negotiations for the first time and capping seniors’ drug expenses to $2,000 per year...

Via Benzinga

Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus ↗

August 12, 2022

New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area.

Via Benzinga

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in GSK plc with Losses of $100,000 to Contact the Firm

August 12, 2022

From The Schall Law Firm

Via Business Wire

Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke ↗

August 11, 2022

Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 11, 2022

On Thursday, 22 companies reached new 52-week lows.

Via Benzinga

GSK, PFE, SNY Stocks Fall on Zantac Litigation ↗

August 11, 2022

You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.

Via InvestorPlace

Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms ↗

August 11, 2022

These companies are at the center of lawsuits claiming Zantac causes cancer.

Via Investor's Business Daily

Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

August 11, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 10, 2022

During Wednesday, 52 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.